EURO (EURO) Fair Value & Analysis

Healthcare · PH · Market cap 7.7B PHP

E EURO EURO · PSE

Price1.07 PHP

Fair Value0.7800 PHP

Upside-27.1%

Quality92/100

Evidence: High Range 0.6300 PHP – 1.20 PHP

Fair value as of: Jun 24, 2026

From 19 valuation models · updated 5 days ago

Share price +2.9% over the past month.

Price vs Fair Value (12 months)

12‑month range 0.7585 PHP – 1.19 PHP · fair‑value band 0.6300 PHP – 1.20 PHP · the 1.07 PHP price screens above the 0.7800 PHP fair value. As of Jun 24, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

EURO (EURO) currently trades at 1.07 PHP, while our model-based Fair Value estimate is 0.7800 PHP — implying the stock looks roughly 27.1% overvalued today. We read business quality at 92/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).

The stock trades on a trailing P/E of 19.4. Fundamentals as of Jun 24, 2026

Revenue & earnings trend

FY2020 – FY2024 · reported fiscal years

EURO reported revenue of 5.8B PHP in FY2024 versus 3.8B PHP in FY2020, a compound +10.9%/yr. Reported net income was 338M PHP in FY2024, compounding +12.6%/yr from FY2020.

Revenue +10.9%/yr

FY20 3.8B PHP

FY21 3.6B PHP

FY22 4.2B PHP

FY23 5.3B PHP

FY24 5.8B PHP

Net income +12.6%/yr

FY20 210M PHP

FY21 169M PHP

FY22 200M PHP

FY23 290M PHP

FY24 338M PHP

Open the full interactive analysis →

Similar stocks

6 more Pharmaceuticals stocks, each showing price versus our Fair Value estimate (as of Jun 24, 2026).

Stock	Price	Fair Value	vs Fair Value
ST Pharm Co 237690	117,800 KRW	62,226 KRW	-47%
NatureCell Co 007390	25,100 KRW	6,531 KRW	-74%
Oscotec Inc 039200	37,000 KRW	34,117 KRW	-8%
DongKook Pharmaceutical Co 086450	18,190 KRW	29,830 KRW	+64%
Kolon Life Science Inc 102940	45,000 KRW	37,195 KRW	-17%
Komipharm International Co 041960	8,120 KRW	949.94 KRW	-88%

Explore undervalued stocks

More undervalued Healthcare stocks →

All undervalued stocks Technology Financial Services Healthcare Consumer Cyclical Consumer Defensive Communication Services Industrials Energy Basic Materials Real Estate Utilities Deeply Undervalued Stocks Undervalued Blue-Chip Stocks Undervalued Small-Cap Stocks

Frequently asked questions

Is EURO (EURO) undervalued?

As of Jun 24, 2026, our model estimates a fair value of 0.7800 PHP versus a price of 1.07 PHP — about −27% (overvalued). Model-based estimate, not financial advice.

What is the fair value of EURO?

Our 21-model fair value for EURO is 0.7800 PHP (as of Jun 24, 2026), built from audited fundamentals. The current price is 1.07 PHP.

What is the quality score of EURO?

EURO has a Quality Score of 92/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

What is the net profit margin of EURO?

The net profit margin of EURO is about 0.0%, meaning it keeps roughly 0.0% of revenue as net income. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.